Opulence Group - ELEVATION. INNOVATION. TRANSCENDENCE.

A novel multinational partnership is stimulating Chinese investment in the GCC

Opulence Capital Management and LWK + PARTNERS have linked an expansive partnership that will support and strengthen the bilateral relations of the People's Republic of China and the Kingdom of Saudi Arabia.

Two S Holding to invest $2.5bn in Nano Cures global healthcare platform

Two S Holding, a part of the UAE Ruling Family's sovereign and royal wealth network, has committed to a $2.5 billion equity investment in Nano Cures International Ltd, an Abu Dhabi based global healthcare technology company.

Arm Chips In to Saudi Arabia Healthcare Revolution

Cambridge superchip architect Arm is to jointly design chips with Nano Cures International – an Abu Dhabi-based global healthcare technology company – to revolutionise Saudi Arabia’s healthcare system in a £28.5 billion initiative.

Arm Holdings Technology To Power Saudi Arabia’s Healthcare Transformation

ARM Holdings, the UK’s flagship technology company, through joint chip designs with Nano Cures International, a global healthcare technology company, will power the infrastructure and technological transformation of the Kingdom of Saudi Arabia’s broader healthcare system.

HIF and Nano Cures: Transforming Healthcare In Saudi Arabia

Nano Cures has been active in the KSA, performing due diligence and auditing existing healthcare infrastructures, and utilizing on-the-ground teams in collaboration with regional technological and financial partners including Opulence Capital Management, Al Quraishi Group and the HIF (Ha’il Investment Fund). HIF’s royal mandate is to incubate and develop innovative technology, healthcare, and industry from around the globe for the region of Ha’il and Kingdom of Saudi Arabia.

Coronavirus Report: The Hill’s Steve Clemons interviews Steve Papermaster

The Hill’s Steve Clemons interviews Steve Papermaster, CEO of Nano Vision and science adviser to former President George W. Bush. Read excerpts from the interview below.

Is Nano Vision's drive for better healthcare research using AI and blockchain a field of dreams?

Nano Vision is building a global, decentralized blockchain platform for healthcare researchers and others to share data and accelerate cures and breakthroughs. Will researchers use it?

Nano Global and Arm to develop AI chip for health data capture

Molecular data firm Nano Global is set to use semiconductor IP company Arm’s intellectual property (IP) for the development of an artificial intelligence (AI) chip to capture health-related molecular data.

Nano Global, Arm Collaborate on Artificial Intelligence Chip to Drive Health Revolution by Capturing and Analyzing Molecular Data in Real Time

Nano Global, an Austin-based molecular data company, today announced that it is developing a chip using intellectual property from Arm, the world’s leading semiconductor IP company. The technology will help redefine how global health challenges, from superbugs to infectious diseases and cancer, are conquered.

Can a High-Tech Chip Conquer Global Health Challenges?

A molecular data company is developing a chip that leverages nanotechnology, optics, artificial intelligence, blockchain authentication, and edge computing to access and analyze molecular-level data in real time.

UAE based Opulence Capital Management confirms commitment for Nano Cures Inc $90 Million Funding round.

Dubai: Nano Cures Inc. (“Nano”), a clinical stage biotechnology and infectious disease immunity platform company based out of USA, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence Capital Management, a Dubai based private investment fund, with existing and new investors participating.

Vanderhey Moody Partners with Lottery.com to Grow Dynamic Gaming Startups

The new gaming incubator that will be formed as a result of the partnership between Vanderhey Moody & Co. LLP ("Vanderhey Moody"), a private equity fund, and Lottery.com (NASDAQ:TDACU) is expected to help to solve key industry-specific problems. Crucially, it will target entrepreneurs and middle-market gaming corporations that lack experience in leveraging resources and in growing their companies to the next level.

Dubai-based Opulence Capital invests $20 million in Nano Cures for global expansion

Nano Cures, a clinical stage biotechnology and infectious disease immunity platform company, has received $90 million pre-IPO funding round that included $20 million from Opulence Capital Management, a Dubai based private investment fund. The investment will accelerate the global scale up of Nano’s Cures Platform for Covid-19 variants, including vaccines and persistent immunity delivery. The company will open up its Cures Platform to other pharmaceutical companies and their vaccines, providing dynamic new ways to conquer the pandemic and deliver billions of doses directly to those in need.